IBDEI3AI ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,52507,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,52507,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,52508,0)
 ;;=E11.628^^194^2540^30
 ;;^UTILITY(U,$J,358.3,52508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52508,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
 ;;^UTILITY(U,$J,358.3,52508,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,52508,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,52509,0)
 ;;=E11.630^^194^2540^33
 ;;^UTILITY(U,$J,358.3,52509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52509,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,52509,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,52509,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,52510,0)
 ;;=E11.638^^194^2540^29
 ;;^UTILITY(U,$J,358.3,52510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52510,1,3,0)
 ;;=3^DM Type 2 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,52510,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,52510,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,52511,0)
 ;;=E11.641^^194^2540^20
 ;;^UTILITY(U,$J,358.3,52511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52511,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,52511,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,52511,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,52512,0)
 ;;=E11.649^^194^2540^21
 ;;^UTILITY(U,$J,358.3,52512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52512,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,52512,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,52512,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,52513,0)
 ;;=E11.65^^194^2540^17
 ;;^UTILITY(U,$J,358.3,52513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52513,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,52513,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,52513,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,52514,0)
 ;;=E11.69^^194^2540^32
 ;;^UTILITY(U,$J,358.3,52514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52514,1,3,0)
 ;;=3^DM Type 2 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,52514,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,52514,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,52515,0)
 ;;=E11.8^^194^2540^34
 ;;^UTILITY(U,$J,358.3,52515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52515,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,52515,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,52515,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,52516,0)
 ;;=E11.9^^194^2540^35
 ;;^UTILITY(U,$J,358.3,52516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52516,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,52516,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,52516,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,52517,0)
 ;;=E11.29^^194^2540^27
 ;;^UTILITY(U,$J,358.3,52517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52517,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,52517,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,52517,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,52518,0)
 ;;=E11.311^^194^2540^14
 ;;^UTILITY(U,$J,358.3,52518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52518,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,52518,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,52518,2)
 ;;=E11.319^5002632
 ;;^UTILITY(U,$J,358.3,52519,0)
 ;;=E11.319^^194^2540^15
 ;;^UTILITY(U,$J,358.3,52519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52519,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,52519,1,4,0)
 ;;=4^E11.319
